Nov 11 (Reuters) - Shares in Evotec (EVTG.DE), opens new tab soared 22% on Monday after private equity firm Triton confirmed a close to 10% stake in the German drug development company, and a media ...
We have recently updated a report on Triton International Limited TRTN. The long-term expected earnings per share (three to five years) growth rate for Triton is pegged at 10%. Triton has an ...
KNDS reaches agreement with Triton on transfer of Renk shares Franco-German defence contractor KNDS has reached an amicable agreement with private equity group Triton on the transfer of shares in ...